In this systematic review of the literature, we summarized publications on onabotulinumtoxinA injections in adult patients treated for upper- or lower-limb spasticity. Our goal was to review the ...

The indication for adult upper limb spasticity treatment now includes elbow and forearm muscles, intrinsic hand muscles, and thumb muscles. The Food and Drug Administration (FDA) has expanded the ...

The Food and Drug Administration (FDA) has approved Botox (onabotulinumtoxinA; Allergan) for the treatment of upper limb spasticity in pediatric patients 2-17 years of age. The approval was based on ...

What Is Upper Limb Spasticity? Upper limb spasticity is a condition that affects the way you move your arms. It makes your muscles stiff and flexed. Sometimes, your arms will twitch or move in a way ...

Many stroke patients suffer from spasticity of the arm that cause pain and impaired sensorimotor function. But there are ways of identifying such patients ahead of time so that they can obtain the ...

— Achieved key co-primary endpoint on efficacy, with 500U dose demonstrating statistically significant difference from placebo in the Modified Ashworth Score (MAS) improvement from baseline — ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a label expansion for Botox to include eight new muscles and the use of ultrasound for the ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced an ...

A advancement in the diagnosis of upper limb (UL) spasticity is on the horizon, moving beyond traditional reliance on clinicians' tactile assessments. Researchers affiliated with UNIST have developed ...

The majority of the 70 primary studies (comprising 2,163 patients) were conducted in Europe (n = 35) or North America (n = 18), while nine studies were completed in Asia and eight in other geographic ...